Independent directory Public ClinicalTrials.gov records United States
ClinicalTrials.gov record
Completed Phase 4 Interventional Accepts healthy volunteers Results available

Concomitant Administration of 13-valent Pneumococcal Conjugate Vaccine (13vPnC) With Influenza Vaccine in 23-valent Pneumococcal Polysaccharide (23vPS) Pre-vaccinated Adults.

ClinicalTrials.gov ID: NCT02124161

Public ClinicalTrials.gov record NCT02124161. Field values are reproduced from the official study page; the official ClinicalTrials.gov record remains the source of truth for eligibility, enrollment, and contact information.

ClinicalTrials.gov public records Last synced Oct 26, 2026, 8:51 PM EDT

Data is sourced from official ClinicalTrials.gov public API records. Always review the official ClinicalTrials.gov record for the latest information.

Official title

A Phase 4, Randomized, Double-blind Trial To Evaluate The Immunogenicity And Safety Of A 13-valent Pneumococcal Conjugate Vaccine When Administered Concomitantly With Seasonal Inactivated Influenza Vaccine In Adults 50 Years And Older Who Received 1 Or More Doses Of 23-valent Pneumococcal Polysaccharide Vaccine Prior To Study Enrollment.

Brief summary

Reproduced verbatim from the official ClinicalTrials.gov record. Not medical advice.

The purpose of this study is to evaluate the immunogenicity and safety of 13-valent pneumococcal polysaccharide vaccine when given concomitantly with seasonal inactivated influenza vaccine to adults 50 years and older who have previously received 23-valent pneumococcal polysaccharide vaccine.

Study identification

NCT ID
NCT02124161
Recruitment status
Completed
Study type
Interventional
Phase
Phase 4
Lead sponsor
Pfizer
Industry
Enrollment
882 participants

Conditions and interventions

Eligibility (public fields only)

Age range
50 Years and older
Sex
All
Healthy volunteers
Accepts healthy volunteers

This page does not interpret eligibility. Detailed inclusion and exclusion criteria are on the official ClinicalTrials.gov record.

Study timeline

Start date
Sep 2014 (Type not available)
Primary completion
May 2015 (Actual)
Completion
May 2015 (Actual)
Last update posted
Jul 1, 2016

2014 – 2015

United States locations

U.S. sites
44
U.S. states
20
U.S. cities
40
Facility City State ZIP Site status
Achieve Clinical Research, LLC Birmingham Alabama 35216 —
Optimal Research (Formerly Accelovance) Huntsville Alabama 35802 —
Radiant Research, Inc. Scottsdale Arizona 85251 —
Kaiser Permanente Vaccine Study Center Oakland California 94612 —
Kaiser Permanante South. Sacramento Sacramento California 95823 —
Benchmark Research San Francisco California 94108 —
Kaiser Pemanente Santa Clara Santa Clara California 95051 —
Avail Clinical Research, LLC DeLand Florida 32720 —
Westside Center for Clinical Research Jacksonville Florida 32205 —
Jacksonville Center for Clinical Research Jacksonville Florida 32216 —
Radiant Research, Inc. Pinellas Park Florida 33781 —
Meridian Clinical Research Savannah Georgia 31406 —
Optimal Research, LLC Mishawaka Indiana 46545 —
Clinical Research Advantage, Inc/Ridge Family Practice Council Bluffs Iowa 51503 —
Johnson County Clin-Trials, Inc. Lenexa Kansas 66219 —
Benchmark Research Metairie Louisiana 70002 —
Meridian Clinical Research Bellevue Nebraska 68005 —
Meridian Clinical Research Norfolk Nebraska 68701 —
Meridian Clinical Research, LLC Omaha Nebraska 68134 —
Clinical Research Center of Nevada, LLC Las Vegas Nevada 89104 —
Clinical Research Advantage, Inc. Las Vegas Nevada 89128 —
United Medical Associates Binghamton New York 13901 —
Regional Clinical Research, Inc. Endwell New York 13760 —
Rochester Clinical Research, Inc. Rochester New York 14609 —
PMG Research of Raleigh, LLC d/b/a PMG Research of Cary Cary North Carolina 27518 —
PharmQuest Greensboro North Carolina 27408 —
PMG Research of Hickory, LLC Hickory North Carolina 28602 —
Clinical Trials of America, Inc. Winston-Salem North Carolina 27103 —
PMG Research of Winston-Salem Winston-Salem North Carolina 27103 —
Radiant Research, Inc Columbus Ohio 43212 —
Prestige Clinical Research Franklin Ohio 45005 —
Preferred Primary Care Physicians, Inc. Carnegie Pennsylvania 15106 —
Brandywine Clinical Research Downingtown Pennsylvania 19335 —
Omega Medical Research Warwick Rhode Island 02886 —
PMG Research of Charleston Mt. Pleasant South Carolina 29464 —
Internal Medicine and Pediatric Associates of Bristol, PC Bristol Tennessee 37620 —
Volunteer Research Group Knoxville Tennessee 37920 —
Benchmark Research Austin Texas 78705 —
Benchmark Research Fort Worth Texas 76735 —
Diagnostics Research Group San Antonio Texas 78229 —
Radiant Research, Inc. Murray Utah 84123 —
J. Lewis Research, Inc. / Foothill Family Clinic Salt Lake City Utah 84109 —
J. Lewis Research, Inc. / Foothill Family Clinic South Salt Lake City Utah 84121 —
J. Lewis Research, Inc. / Jordan River Family Medicine South Jordan Utah 84095 —

Site contact phone numbers, emails, and investigator names are intentionally not displayed here. Open the official ClinicalTrials.gov record for site contact information.

About this trial record page

What this page shows
Public field values for ClinicalTrials.gov record NCT02124161, including study identification, conditions, interventions, eligibility (age, sex, healthy volunteer), timeline, and U.S. site list.
What this page does not do
No medical advice, eligibility judgments, treatment recommendations, study quality scoring, or AI-generated medical summaries. No site contact phone numbers, emails, or investigator names.
Where the data comes from
Sourced from the official ClinicalTrials.gov public API. The official record is the source of truth.
Last refresh
Last update posted Jul 1, 2016 · Synced Oct 26, 2026

Related: full search, browse by condition, browse by drug or therapy, browse by sponsor, browse by U.S. city.

Open the official record

The complete public registry record, listed eligibility criteria, and available contact information for NCT02124161 live on ClinicalTrials.gov.

View official ClinicalTrials.gov record →